Briacell Therapeutics (BCTX) Debt by Year
Briacell Therapeutics Corp. held $9.9M in cash and equivalents at the end of fiscal year 2026, and no long-term debt figure is on record for that period. The table below carries 6 fiscal years, from 2021 to 2026, and the quarters Briacell Therapeutics Corp. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
BCTX Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
BCTX Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $9.9M-6.1% | $6.9M-44.8% | $29.9M+496.4% | $2.7M-53.1% | $10.5M+1117.3% | $12.5M+1231.7% | $5.0M-19.7% | $5.8M-57.6% | $862K-95.9% | $936K-96.7% | $6.2M-81.4% | $13.6M-63.6% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Briacell Therapeutics Corp. financials
Frequently Asked Questions
Briacell Therapeutics Corp. held $9.9M in cash and equivalents at the end of fiscal year 2026, and no long-term debt figure is on record for that period.
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Briacell Therapeutics Corp. (BCTX) reported on that line in every period on record.